Bioservo develops the next generation of rehabilitative gloves
Bioservo Technologies AB has received financing of SEK 5 million within the Horizon 2020 framework to develop the next generation of rehabilitative and assistive grip-enhancing gloves. By offering patients rehabilitation at home and in daily activities, they can become more independent, the rehabilitation process is made more efficient and care costs are reduced.
The next generation of Carbonhand, our grip-enhancing glove for medical use, will enable people with disabilities to carry out rehabilitation at home while receiving help with daily activities. There is a great need to streamline rehabilitation by treating impaired hand functions at an early stage and making recovery faster, more efficient, and more independent. The future glove will be combined with software that monitors patients’ progress, as well as a mobile application that gives healthcare providers access to patients’ results remotely.
The project, which runs over three years, is carried out in collaboration with Roessingh Research and Development (RRD) in the Netherlands, one of Europe's largest research centers for technical aids, rehabilitation technology and analysis of human movements. RRD will be responsible for requirements analysis and pilot testing with users.
“Within the project, we will develop a new generation of our medical device Carbonhand, a product that will enable us to open up new markets. Several clinical and pilot studies have shown great potential for the glove to be used as a therapeutic device.” says Petter Bäckgren, CEO of Bioservo, and continues, "Collected feedback has shown that there is a market need and a readiness for a glove with a therapeutic effect for targeted treatments in a more effective way."
For more information, please contact
Petter Bäckgren, CEO, Bioservo Technologies AB
Phone: +468 21 17 10
Niklas Lagström, Global Brand Manager – Life Science, Bioservo Technologies AB
Phone: +468 21 17 10
About Bioservo Technologies
Bioservo Technologies AB (publ) is a world leading company in wearable muscle strengthening systems for people in need of extra strength and endurance. All our innovative products and systems are designed to keep people strong, healthy and efficient.
The company has a unique global position within soft exoskeleton technology for the hand, both for industrial applications to improve the health for workers and to improve quality of life for people with reduced muscle strength.
Bioservo Technologies was founded in 2006 in collaboration between researchers at the Royal Institute of Technology and a doctor at Karolinska University Hospital. Bioservo Technologies is a Swedish public limited company with headquarters in Stockholm.
FNCA Sweden AB, +46(0)8-52800399, email@example.com is the company’s Certified Adviser on Nasdaq First North Growth Market.
For more information, please visit www.bioservo.com
About Roessingh Research and Development
Roessingh Research and Development (RRD) is a large scientific research institute focused on rehabilitation technology and eHealth. RRD works closely with Roessingh, Centre for Rehabilitation and the University of Twente in the field of rehabilitation technology and eHealth, but also with international partners. For more information, please visit www.rrd.nl